Court Dismisses Suit Over Drug Makers’ 340B Discount Limits, Says Use ADR First

By Michelle M. Stein / February 19, 2021 at 8:30 AM
A federal court on Wednesday (Feb. 17) dismissed hospitals and pharmacists’ lawsuit over drug makers’ limitations on 340B discounts available via contract pharmacies and told the providers to first take their concerns through HHS’ new administrative dispute resolution process. A day earlier, HHS defended the ADR process in a separate suit by Eli Lilly challenging that process and alleged Eli Lilly was trying to get the court to agree with the company’s rewrite of the 340B program. The U.S. District...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.